Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

830 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma.
Gohara S, Shinohara K, Yoshida R, Kariya R, Tazawa H, Hashimoto M, Inoue J, Kubo R, Nakashima H, Arita H, Kawaguchi S, Yamana K, Nagao Y, Iwamoto A, Sakata J, Matsuoka Y, Takeshita H, Hirayama M, Kawahara K, Nagata M, Hirosue A, Kuwahara Y, Fukumoto M, Okada S, Urata Y, Fujiwara T, Nakayama H. Gohara S, et al. Among authors: takeshita h. Mol Ther Oncolytics. 2022 Oct 8;27:141-156. doi: 10.1016/j.omto.2022.10.001. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36381653 Free PMC article.
Extracellular vesicles derived from radioresistant oral squamous cell carcinoma cells contribute to the acquisition of radioresistance via the miR-503-3p-BAK axis.
Yamana K, Inoue J, Yoshida R, Sakata J, Nakashima H, Arita H, Kawaguchi S, Gohara S, Nagao Y, Takeshita H, Maeshiro M, Liu R, Matsuoka Y, Hirayama M, Kawahara K, Nagata M, Hirosue A, Toya R, Murakami R, Kuwahara Y, Fukumoto M, Nakayama H. Yamana K, et al. Among authors: takeshita h. J Extracell Vesicles. 2021 Dec;10(14):e12169. doi: 10.1002/jev2.12169. J Extracell Vesicles. 2021. PMID: 34894384 Free PMC article.
Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistance.
Kanemaru A, Shinriki S, Kai M, Tsurekawa K, Ozeki K, Uchino S, Suenaga N, Yonemaru K, Miyake S, Masuda T, Kariya R, Okada S, Takeshita H, Seki Y, Yano H, Komohara Y, Yoshida R, Nakayama H, Li JD, Saito H, Jono H. Kanemaru A, et al. Among authors: takeshita h. Cancer Cell Int. 2022 Nov 15;22(1):358. doi: 10.1186/s12935-022-02781-x. Cancer Cell Int. 2022. PMID: 36376983 Free PMC article.
FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells.
Takeshita H, Yoshida R, Inoue J, Ishikawa K, Shinohara K, Hirayama M, Oyama T, Kubo R, Yamana K, Nagao Y, Gohara S, Sakata J, Nakashima H, Matsuoka Y, Nakamoto M, Hirayama M, Kawahara K, Takahashi N, Hirosue A, Kuwahara Y, Fukumoto M, Toya R, Murakami R, Nakayama H. Takeshita H, et al. Lab Invest. 2023 May;103(5):100060. doi: 10.1016/j.labinv.2022.100060. Epub 2023 Jan 10. Lab Invest. 2023. PMID: 36801643 Free article.
The relationship between a comprehensive index of prosperity and suicide rates in former Soviet countries, including a comparison with European and Asian countries: Discussion from a new perspective.
Inoue K, Apbassova M, Seksenbayev N, Toleuov E, Akkuzinova K, Karimova Z, Moldagaliyev T, Ospanova N, Apbassova S, Chaizhunusova N, Shabdarbayeva D, Dyussupov A, Takeshita H, Kawano N. Inoue K, et al. Among authors: takeshita h. Leg Med (Tokyo). 2024 May 10;69:102460. doi: 10.1016/j.legalmed.2024.102460. Online ahead of print. Leg Med (Tokyo). 2024. PMID: 38739974
Evaluation of the advantage of surgeons certified by the endoscopic surgical skill qualification system participating in laparoscopic low anterior rectal resection.
Sawada N, Akagi T, Shimomura M, Todate Y, Nagakari K, Takeshita H, Maruyama S, Takata M, Ichikawa N, Hida K, Iijima H, Yamaguchi S, Taketomi A, Naitoh T; EnSSURE Study Group Collaboratives in Japan Society of Laparoscopic Colorectal Surgery.. Sawada N, et al. Among authors: takeshita h. Ann Gastroenterol Surg. 2023 Dec 14;8(3):464-470. doi: 10.1002/ags3.12763. eCollection 2024 May. Ann Gastroenterol Surg. 2023. PMID: 38707236 Free PMC article.
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Massari F, Santoni M, Takeshita H, Okada Y, Tapia JC, Basso U, Maruzzo M, Scagliarini S, Büttner T, Fornarini G, Myint ZW, Galli L, Souza VC, Pichler R, De Giorgi U, Gandur N, Lam ET, Gilbert D, Popovic L, Grande E, Mammone G, Berardi R, Crabb SJ, Kemp R, Molina-Cerrillo J, Freitas M, Luz M, Iacovelli R, Calabrò F, Tural D, Atzori F, Küronya Z, Chiari R, Campos S, Caffo O, Fay AP, Kucharz J, Zucali PA, Rinck JA, Zeppellini A, Bastos DA, Aurilio G, Mota A, Trindade K, Ortega C, Sade JP, Rizzo M, Fiala O, Vau N, Giannatempo P, Barillas A, Monteiro FSM, Dauster B, Mennitto A, Nogueira L, de Carvalho Fernandes R, Seront E, Aceituno LG, Grillone F, Cutuli HJ, Fernandez M, Bassanelli M, Kopp RM, Roviello G, Abahssain H, Procopio G, Milella M, Kopecky J, Martignetti A, Messina C, Caitano M, Inman E, Kanesvaran R, Herchhorn D, Santini D, Bamias A, Bisonni R, Mosca A, Morelli F, Maluf F, Soares A, Nunes F, Pinto A, Zgura A, Incorvaia L, Ansari J, Zabalza IO, Landmesser J, Rizzo A, Mollica V, Marchetti A, Rosellini M, Sorgentoni G, Battelli N, Buti S, Porta C, Bellmunt J. Massari F, et al. Among authors: takeshita h. Cancer Immunol Immunother. 2024 Apr 18;73(6):106. doi: 10.1007/s00262-024-03682-w. Cancer Immunol Immunother. 2024. PMID: 38634928 Free PMC article.
830 results